Cargando…
Changes in the Bone Mineral Density of Femur Neck and Total Hip Over a 52-Week Treatment with Lobeglitazone
Autores principales: | Lee, Da Young, Seo, Ji A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663676/ https://www.ncbi.nlm.nih.gov/pubmed/29086535 http://dx.doi.org/10.4093/dmj.2017.41.5.374 |
Ejemplares similares
-
Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
por: Lim, Soo, et al.
Publicado: (2017) -
Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice
por: Kim, Kyoung Min, et al.
Publicado: (2017) -
Bone mineral density in fracture neck of femur patients: What's the significance?
por: Elamin Ahmed, Hussam, et al.
Publicado: (2022) -
Prediction of Bone Mineral Density (BMD) Adaptation in Pelvis–Femur Model with Hip Arthroplasties
por: Abdullah, Abdul Halim, et al.
Publicado: (2021) -
Changes in Bone Mineral Density of Both Proximal Femurs after Total Knee Arthroplasty
por: Kim, Kwang Kyoun, et al.
Publicado: (2014)